To assess responses to cancer antigens, T cell responses to overlapping peptides covering tumour associated antigens (TAA) 5T4, DNAJB7, CEACAM, and ZSWIM1 were measured, whilst CEF and CEFTA peptide pools were used to measure T cell responses to common recall antigens. Here, DNAJB7 is linked to cancer.